ROSSI, GIORGIO ETTORE
 Distribuzione geografica
Continente #
EU - Europa 17.676
NA - Nord America 11.237
AS - Asia 10.021
SA - Sud America 964
AF - Africa 230
Continente sconosciuto - Info sul continente non disponibili 60
OC - Oceania 49
Totale 40.237
Nazione #
US - Stati Uniti d'America 10.836
GB - Regno Unito 5.986
CN - Cina 3.618
DE - Germania 3.117
IT - Italia 2.765
SG - Singapore 2.701
RU - Federazione Russa 1.163
SE - Svezia 1.158
HK - Hong Kong 958
FR - Francia 882
BR - Brasile 707
TR - Turchia 644
NL - Olanda 556
IE - Irlanda 551
UA - Ucraina 548
KR - Corea 525
IN - India 508
VN - Vietnam 447
FI - Finlandia 339
EU - Europa 331
CA - Canada 306
ID - Indonesia 135
JP - Giappone 124
CO - Colombia 118
DK - Danimarca 113
CI - Costa d'Avorio 99
ES - Italia 89
PL - Polonia 88
AR - Argentina 67
BE - Belgio 66
GR - Grecia 54
MX - Messico 50
BD - Bangladesh 48
AT - Austria 45
TW - Taiwan 39
UZ - Uzbekistan 39
AU - Australia 38
CH - Svizzera 36
IQ - Iraq 36
EC - Ecuador 25
ZA - Sudafrica 25
PK - Pakistan 23
RO - Romania 21
SA - Arabia Saudita 21
PH - Filippine 20
CL - Cile 19
EG - Egitto 19
PT - Portogallo 19
MA - Marocco 17
AE - Emirati Arabi Uniti 16
TH - Thailandia 16
KE - Kenya 15
CZ - Repubblica Ceca 14
NO - Norvegia 13
TN - Tunisia 11
IL - Israele 10
IR - Iran 10
VE - Venezuela 10
HU - Ungheria 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
PA - Panama 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
JO - Giordania 8
MY - Malesia 8
JM - Giamaica 7
LK - Sri Lanka 7
AL - Albania 6
BG - Bulgaria 6
DZ - Algeria 6
ET - Etiopia 6
LB - Libano 6
LU - Lussemburgo 6
NP - Nepal 6
PR - Porto Rico 6
EE - Estonia 5
NG - Nigeria 5
UY - Uruguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
ML - Mali 4
PS - Palestinian Territory 4
PY - Paraguay 4
BO - Bolivia 3
CR - Costa Rica 3
IS - Islanda 3
KH - Cambogia 3
LV - Lettonia 3
MD - Moldavia 3
NI - Nicaragua 3
PE - Perù 3
TJ - Tagikistan 3
YE - Yemen 3
BS - Bahamas 2
GE - Georgia 2
Totale 40.469
Città #
Southend 5.589
Frankfurt am Main 1.964
Singapore 1.520
Chandler 1.092
Ashburn 936
Hong Kong 901
Seattle 815
Milan 744
Beijing 698
Princeton 633
Dublin 545
Dallas 491
Wilmington 490
Council Bluffs 379
Jacksonville 339
Dearborn 328
Ann Arbor 320
Redmond 306
Fairfield 277
Santa Clara 276
Bengaluru 275
Los Angeles 265
Nanjing 238
Des Moines 221
Toronto 214
Sakarya 213
Mountain View 201
Woodbridge 180
Buffalo 171
Levico Terme 168
Houston 161
Boardman 148
Guangzhou 138
Shanghai 138
Moscow 126
Serra 115
Dong Ket 111
Bogotá 101
Abidjan 99
Andover 99
Rome 98
Munich 97
Shenyang 97
Hefei 94
Phoenix 90
Redwood City 89
Cambridge 88
Jinan 87
Cangzhou 85
New York 84
Hanover 80
Istanbul 80
Tianjin 76
Nanchang 75
Warsaw 74
São Paulo 72
Jakarta 71
Somerville 70
Ho Chi Minh City 69
Changsha 68
Columbus 66
Hebei 64
Grafing 63
Berlin 61
The Dalles 57
Hangzhou 56
San Diego 52
Tokyo 52
Fuzhou 51
Hanoi 50
Bologna 49
Athens 48
Eitensheim 48
Zhengzhou 48
Nuremberg 47
Chicago 45
Helsinki 45
Seoul 45
Brussels 42
Turin 42
Jiaxing 37
London 37
Saint Petersburg 36
Kiez 35
Wuhan 34
Pavia 33
Pisa 33
Turku 33
Chengdu 32
Bitonto 30
Mumbai 30
Fremont 29
Verona 29
Kunming 26
Naples 26
Florence 25
Taizhou 25
Ottawa 24
Quanzhou 24
Madrid 23
Totale 25.301
Nome #
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 799
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 620
Disfunzione erettile nel paziente sottoposto a trapianto di fegato: ruolo del sildenafil 598
Sequential use of normothermic regional and ex-situ machine perfusion in DCD liver transplant 513
Multimodality treatment of hepatocellular carcinoma : How field practice complies with international recommendations 424
Endo-therapies for biliary duct-to-duct anastomotic stricture after liver transplantation: outcomes of a nationwide survey 376
No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants 352
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation 325
The role of ex-situ hypothermic oxygenated machine perfusion and cold preservation time in extended criteria DCD and DBD 325
A prospective randomized, open-labeled; trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma 281
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 276
Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma 254
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 251
Donor/recipient match of IL28B to predict interferon response in recurrent hepatitis C 246
Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men 245
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 235
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 232
Thrombosis after liver transplantation for hepatocellular carcinoma 223
Graft Portal Vein Thrombosis Before Liver Transplant 220
Results in 50 orthotopic liver transplants in Milan 213
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 210
Incidence and risk factors of acute kidney injury and failure after liver transplantation in patients with normal kidney function 209
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation : preliminary results 206
Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantation 205
B hepatitis and liver transplantation 205
Organ procurement for multivisceral abdominal transplantation in the pig 204
Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma 204
ERCP in the management of anastomotic biliary stricture after liver transplantation 201
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients 199
Ex-Vivo Lung Perfusion (EVLP) in the process of donor lung assessment 199
Alteration in the transcriptional profile of livers from brain-dead organ donors 198
Migration rate using fully covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT study group 194
Prospective randomized multicentre phase III study of liver perfusion with HTK solution compared with UW OR celsior solutions in the setting of liver transplantation 193
Management of Biliary Anastomotic Strictures After Liver Transplantation (BASALT Study): a Nationwide Italian Survey 192
D-MELD, a powerful predictor of graft survival after liver transplantation. Long-term results of a multicenter italian study 191
Serum autoantibodies correlates with severity of hepatitis c recurrence after liver transplant 186
Bleeding after sphincterotomy and need of haemostosis in liver transplanted patients 186
A multicenter italian experience in spli-liver transplantation : 10 year follow-up of a case control study 185
Liver Match, a prospective observational cohort study on liver transplantation in Italy : study design and current practice of donor-recipient matching 183
Visceral artery aneurysms in liver transplant candidates and in patients after liver transplantation 183
Bench reconstruction of the graft arterial supply in liver transplantation 180
Liver retransplantation in adults : the Largest Multicenter Italian Study 180
Higher rate of bleeding after sphincterotomy in liver transplanted patients 177
Back.table arterial reconstruction in liver transplantation: single-center experience 177
Infezioni da mycobatteri non turercolotici nel paziente trapiantato di polmone 176
Hepatic stem cell characterization in tumoral and non-tumoral liver specimens from patients with hepatocellular carcinoma 175
Portal vein arterialization for hepatic artery thrombosis in liver transplantation : a case report, Doppler-ultrasound aspects, and review of the literature 175
Results of 24 orthotopic liver transplants in Milan 175
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 173
HCC recurrence in HCV-infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs - a post-hoc analysis 172
Coronavirus disease 2019 and transplantation: tackling the challenges of SARS-CoV-2 infection in waiting list candidates 171
Total hepatectomy and rescue liver transplantation after 38 hours of anhepatic state 170
Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantation 169
Liver transplantation in patients with cystic fibrosis 167
Prenatal and accurate perinatal diagnosis of type 2 H or ductular duplicate gallbladder 167
Effects of liver transplantation on the nutritional status of patients with cystic fibrosis 166
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of liver graft hepatitis C recurrence 166
Immunologic study of orthotopic liver-small bowel transplantation in the pig 166
Aspergillus fumigatus infections in liver transplant patients 166
A giant adrenal myelolipoma in a beta-thalassemia major patient : Does ineffective erythropoiesis play a role? 166
Detection of autoantibodies against cytochrome P450 2E1 (CYP2E1) in patients with recurrent hepatitis C 165
Serum autoantibodies against cytochrome P450 2EI (CYP2EI) predict severity of liver graft hepatitis C recurrence 165
Management of hepatocellular carcinoma in the time of COVID-19 165
Protocol liver biopsies to evaluate severity of recurrent HCV hepatitis : a recent monocentric experience 163
Single-versus multidetector-row CT : comparison of sedation rates, conventional angiograms and motion artefacts in young children following liver transplantation 162
Veno-venous extracorporeal circulation in orthotopic transplant of the liver. Experimental study 162
A national mandatory-split liver policy: A report from the Italian experience 162
Supporto respiratorio extracorporeo con by-pass veno-venoso come ponte al trapianto di polmone. Nostra iniziale esperienza 161
Child-Pugh score and liver transplantation 160
Liver transplanted patients bleed after endoscopic sphincterotomy more frequently 159
Orthotopic transplantation of partially hepatectomized liver in the pig 159
Role of Preoperative Biliary Drainage in Resectable Hilar Cholangiocarcinoma 159
Back-table surgery for liver grafts 158
An easy high-performance liquid chromatography quantification of monosaccharides from ileal mucosal tissue glycoproteins in pigs 158
Behind D-MELD : The role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants 157
Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft 157
Il trapianto di fegato 156
Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature 156
Successful loco-regional thrombolytic treatment of the aortic conduit in a patient with orthotopic liver transplantation: a case report 155
The un-sustainable match in HCV liver transplant patients 155
Combined liver-kidney transplantation in glycogen storage disease Ia : a case beyond the guidelines 154
Liver transplantation in patients with B viral hepatitis and delta infection 154
Stent-trial in anastomotic biliary structure after liver transplantation : does it help patients' management? 153
Late graft dysfunction (GD) in HBV recurrence-free recipients is associated with serum antinuclear antibodies (ANA) reactivity 153
Graft dysfunction (GD) in HBV recurrence free recipience is associated with serum autoantibodies reactivity 153
The un-sustainable match in HCV recipients : Evidences from the italian D-MELD study on balancing donor-recipent risk factors 153
Sexuality and erectile dysfunction in patients who have undergone liver transplant 153
The activity of the Liver Transplant Center of Milan, Italy 152
Arterial anastomosis in liver transplantation for Rendu-Osler-Weber disease: two case reports 152
Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center in Milan, Italy 152
Long-term results after liver transplantation in B and delta hepatitis 150
Characterization of tumor cell lines generated from primary human hepatocellular carcinoma 150
Reshape and secure HCC managing during COVID-19 pandemic : A single centre analysis of four periods in 2020 versus 2019 150
Evidence of cancer stem cells in primary human hepatocellular carcinoma 149
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience 147
The cyclosporin related toxicity in high risk liver transplant patients 147
Metabolic syndrome after liver transplantation : short-term prevalence and pre- and post-operative risk factors 147
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 146
Transient elastography (TE, Fibroscan) in the evaluation of recurrent disease after liver transplantation (LT) 146
Bleeding after sphincterotomy in liver transplanted patients with biliary complications 146
Totale 20.576
Categoria #
all - tutte 112.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.565 0 0 0 0 0 292 209 273 362 205 840 384
2021/20223.169 250 192 95 156 192 202 231 216 405 360 219 651
2022/20234.292 502 326 322 532 521 855 140 244 489 66 206 89
2023/20243.597 100 220 138 125 564 186 382 344 166 333 545 494
2024/20256.829 428 865 329 712 514 171 186 695 357 591 523 1.458
2025/20265.973 1.304 663 1.314 1.084 1.461 147 0 0 0 0 0 0
Totale 42.424